Skip to content

Construction and application of early progressive activity program in patients with acute decompensated heart failure based on the Temporal Self-regulation theory

Construction and application of early progressive activity program in patients with acute decompensated heart failure based on the Temporal Self-regulation theory

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080376
Enrollment
Unknown
Registered
2024-01-29
Start date
2024-01-30
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute decompensated heart failure

Interventions

intervention group:Bed exercise stage: passive joint exercise (5 times for 1 set, 3 to 5 sets, each lasting 10 to 20min), active joint exercise (5 times for 1 set, 3 to 5 sets, each lasting 10 to 20mi
control group :Routine activity guidance measures

Sponsors

Affiliated Hangzhou First People's Hospital of Westlake University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: ?=18 years of age;?Acute decompensated heart failure was diagnosed after admission;?New York Heart Association (NYHA) Grade I to III cardiac function;?Patients or their family members participated voluntarily and signed informed consent.

Exclusion criteria

Exclusion criteria: ?End-stage patients with diseases of brain, liver, lung, kidney and other important organs;?Patients with persistent consciousness or communication disorders, unable to communicate effectively and their caregivers unable to provide effective information;?Active contraindications: early stage of acute coronary syndrome (within 2d); Malignant arrhythmia; Acute heart failure with hemodynamic instability; Resting blood pressure over 200/110mmHg; High atrioventricular block; Acute myocarditis, pericarditis or endocarditis; Symptomatic severe aortic stenosis; Severe hypertrophic obstructive cardiomyopathy; Acute systemic disease; Intracardiac thrombus; Progressive dyspnea increased or activity tolerance decreased in the past 3 to 5 days; Severe myocardial ischemia ; Diabetic blood glucose control is not ideal; Acute embolism; Thrombophlebitis; New onset of atrial fibrillation or atrial flutter.

Design outcomes

Primary

MeasureTime frame
6 minute walk test, 6MWT;Grip strength test, GS;30s arm flexion test, 30s-ACT;

Secondary

MeasureTime frame
Minnesota living with heart failure questionnaires, MLHFQ;

Countries

China

Contacts

Public ContactXuan Xiulin

Affiliated Hangzhou First People's Hospital of Westlake University School of Medicine

15968394201@163.com+86 159 6839 4201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026